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ABSTRACT Atopic dermatitis (AD) is a frequent dermatosis with a grow-
ing incidence and multifactorial and complex pathogenic mechanisms 
that are still being investigated. Although the connection between AD 
and psychological stress has been known for a long time, there is a lack 
of reliable and objective indicators for the characterization of this asso-
ciation. Psychological stress triggers complex immune pathways. there-
fore, acute stress quickly triggers a high release of cortisol and adrenalin 
or noradrenalin which then stimulates the immune system, primarily t-
helper type 1 (th1 cells) to produce pro-inflammatory cytokines, result-
ing in a cellular immune response and inflammation. On the other hand, 
chronic stress increases basal cortisol levels and decreases the capacity to 
mount an acute stress response, with the immune system shifting from a 
cellular response (which is active in acute stress) to a humoral response. 
Furthermore, skin keratinocytes contain receptors for neurotransmitters 
and hormones (muscarinic, adrenergic, glucocorticosteroid, androgenic, 
estrogenic), thus actively participating in psychoneuroimmunological 
pathways. the measurement of plasmatic cortisol has been used routine-
ly, but in recent years, particularly in research, preference has been given 
to measurement of salivary cortisol. reliable psychological tests are an 
important additional parameter for assessment of a patient’s psychologi-
cal state. We hope that future studies will supplement our current knowl-
edge on the influence of psychological stress in AD.
KEY WORDS: atopic dermatitis, psychological stress, cortisol, immune 
factors, psychoneuroimmunology
InTRODuCTIOn
Atopic dermatitis (AD) is a chronic dermatosis 
with very diverse clinical manifestations. it is charac-
terized by dryness, recurring skin changes with ery-
thema, and eczema followed by intense skin itching; 
it is associated with immediate allergic hypersensi-
tivity (atopy) and delayed hypersensitivity (1-4). Our 
present knowledge suggests that AD can be caused 
by multiple factors, such as genetic predisposition, 
various allergens, disorders of the humoral and cel-
lular immune responses, disorders of the epidermal 
skin barrier, neurovegetative factors, climate condi-
tions, stress, etc. (2,3). Due to the increasing preva-
lence of AD and the growing expenses required for 
its treatment, extensive research efforts have been 
made in order to obtain a deeper insight into this dis-
ease its pathogenesis in particularly, since this could 
be important in the treatment of patients with AD. 
Although the connection between stress and AD has 
been studied over the years, there is currently great 
interest in the analysis of the influence of stress on AD 
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manifestations, especially when considering recent 
psychoneuroimmunology research. Of the various 
etiological factors which may affect AD, there is still 
a high interest in analysis of the influence of stress, 
especially when considering recent psychoneuroim-
munology research.
Stress and atopic dermatitis – historical 
data
When the impact of stress on the manifestations of 
AD was monitored in patients with AD, deterioration 
of the clinical picture was observed and the impact of 
emotional factors on the severity of the disease was 
demonstrated (5). However, as no general consensus 
on the influence of stress on AD has been reached, 
the need has arisen for achieving deeper insight into 
the fundamental psychobiological mechanisms and 
the ways in which stress can influence AD (6).
the connection between the AD manifestations 
on the one hand and emotional factors and stress 
on the other was noticed and described at the very 
beginning of the research and monitoring of patients 
with AD. early in the last century, AD and asthma were 
primarily considered to be psychosomatic diseases: 
as late as 1950, Alexander (Psychosomatic Medicine) 
describes them as typical representatives of such dis-
eases. Gradually (in the 1930s and 1940s), the view-
point that the AD etiology was of a multifactorial 
nature started to spread, the argument being that 
emotional factors were only one of the triggers con-
tributing to the manifestation and aggravation of the 
disease (7). later, in the 1970s and 1980s – even in the 
1990s – studies on the connection between AD and 
emotional stress focused on the personality traits, or 
“psychological profiles”, of atopic patients (8-14).
thus, in the 1970s and 1980s, numerous studies of 
patients with AD reported increased anxiety, depres-
sion, anger, and hostility, particularly in correlation 
with the severity of their clinical AD manifestations. 
However, these studies were of questionable quality 
because they included small groups of patients, and 
controls were rare. So the question remains whether 
the psychopathological results of the research were 
elucidating of the pathogenesis or whether they 
were an epiphenomenon of a chronic inflammatory 
disease (15). in the late 1990s and in the 2000s, the 
research – primarily in immunology (psychoneuroim-
munology and psychoneuroendocrinology) – led to 
important new discoveries, renewing discussions of 
the influence of stress on the manifestations and se-
verity of AD (6,16-26).
The mechanism of stress impact on atopic 
dermatitis
the research results and insight into psychoneu-
roimmunology obtained thus far strongly confirm 
that stressful life events have a substantial impact 
on the functioning of the immune system (27-29). in 
this context, the hypothalamic-pituitary-adrenal axis 
(HPA) has an important role in the complex response 
to stress. it is well known that stress stimulates the 
secretion of corticotropin-releasing hormone (CrH) 
from the hypothalamus. By means of circulation, CrH 
reaches the pituitary gland and stimulates the secre-
tion of adrenocorticotropic hormone (ACtH), which, 
in turn, affects the adrenal cortex and stimulates the 
secretion of cortisol (28). Cortisol is the main gluco-
corticoid produced in the fasciculate zone of the ad-
renal cortex, where it is synthesized from cholesterol, 
and which has an effect on the inflammatory reac-
tion. it strongly suppresses overall inflammation and, 
consequently, its values increase during stress – not 
just acute, but also chronic stress (30-32). Acute stress 
may induce an individual’s adaptive response to en-
vironmental demands, while chronic, excessive stress 
causes cumulative negative impacts on health out-
comes through “allostatic load” (32). therefore, the 
measurement of chronic stress mediators provides a 
timely opportunity for prevention or earlier interven-
tion of stress-related AD.
Acute and chronic stress have different impacts on 
the immune system (15). Acute stress triggers, within 
only a minute, a high release of cortisol and adrenalin 
or noradrenalin which then stimulates the immune 
system, primarily t-helper type 1 (th1) to produce 
pro-inflammatory cytokines, including iFn-γ, result-
ing in cellular immune response and tissue damage 
(15,33,34). this cortisol secretion in acute stress also 
serves as protection and as an anti-inflammatory 
mechanism for maintaining homeostasis (35).
On the other hand, chronic stress exposure in-
creases basal cortisol levels along with decreasing 
the capacity to mount an acute stress response. in 
this state the immune system shifts from a cellular re-
sponse (which is active in acute stress) to a humoral 
response with a prominent role of cytokines (15). the 
pathogenesis of AD, as a chronic allergic disease, in-
cludes this switch to a humoral immune response 
which is one of its crucial pathogenic mechanisms 
(6,33-35). this enables the immune system to facili-
tate development of autoimmune and atopic dis-
eases. Studies show that epigenetic modification of 
the HPA stress axis makes the individual even more 
susceptible to manifest imbalanced chronic stress 
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response (15). Patients with chronic AD have HPA 
dysfunction, presenting with an attenuated cortisol 
responsiveness after stress exposure which may be a 
reason for the imbalance between humoral and cel-
lular immune response (6). Chronic stress exposure 
leads to a slower rise of morning cortisol and a base-
line secretion of cortisol. 
Another important fact for understanding the 
connection between the skin and psychoneuroim-
munological pathways is the fact that skin keratino-
cytes contain receptors for neurotransmitters and 
hormones (muscarinic, adrenergic, glucocorticoste-
roid (GC), androgenic, estrogenic) (36,37). During 
stress, ACtH secretion-stimulated CrH production 
promotes the generation of pro-inflammatory cyto-
kines in skin keratinocytes, resulting in t-cell activity 
stimulation (38-41). this supports active roles of skin 
cells and other skin structures in inflammation.
in addition to the above-mentioned central HPA 
axis, there is a peripheral (skin) autonomous HPA axis 
stress regulation (as important as the central HPA axis) 
which exists to regulate its homeostasis in response 
to its ongoing exposure to environmental stressors 
(Figure 1) (35). According to the latest knowledge, 
the skin (peripheral) HPA axis plays an important role 
(35). Under stress, skin keratinocytes produce CrH, 
ACtH, and cortisol. it has been confirmed that kera-
tinocytes synthesize cortisol with the help of the 11 
beta-hydroxysteroid dehydrogenase (11beta-HSD) 
enzyme which activates cortisol from cortisone. Fur-
thermore, cortisol impacts the immune system by 
increasing th2 cell activity in chronic stress exposure 
and by regulating skin keratinocyte activity, inducing 
anti-inflammatory effects and disrupting skin barrier 
homeostasis (6,35,41). 
However, the components of this neuroendocrine 
system have been described for many structural cells 
of the skin (e.g. melanocytes, sebocytes, fibroblasts, 
etc.), although they have been particularly well char-
acterized for keratinocytes. it has been reported that 
all regulatory elements of the central HPA axis are 
also expressed in mammalian skin, including CrH, 
pro-opiomelanocortin (POMC) derived peptides, 
GCs, and related peptides, as well as their appropri-
ate functional receptors, CrH receptors, melanocor-
tin receptor type 2 (MCr2, the classical adrenocorti-
cal ACtH receptor), and GC receptor nr3C1 (35). this 
skin axis shows a similar hierarchical structure to the 
central axis. 
Along with HPA central and peripheral axis, there 
is another important effector pathway of stress regu-
lation that involves the sympathetic nervous system 
(SnS). Stimulation of the SnS results in the release of 
catecholamines (adrenalin and noradrenalin) from 
the adrenal cortex and sensory nerve endings (28). 
it is also important that skin cells have receptors and 
react to neurotrophic factors, predominantly kerati-
nocytes but also lymphocytes, macrophages, eosino-
phils, and mastocytes (20).
Substance P and nGF, as a part of another skin 
stress response pathway, are detectable in increased 
levels in animals affected by systemic and local stress 
(38). this pathway is called the neutrophine neuro-
peptide axis (nnA) (15). Substance P is released in the 
skin from peripheral nerve endings and induces infil-
tration of inflammatory cells and tnF, il-1, il-6, and 
il-12 cytokine production (38). it is also responsible 
for triggering an immune system shift to a chronic 
stress response in which the HPA axis is dysfunction-
al (35). Another part of this pathway is neutrophine 
nGF which directly affects keratinocyte proliferation 
and immune cell reactions in inflamed skin (38). Ac-
tivation of this pathway in response to exposure to 
environmental stress showed worsening of the skin 
pictures as observed in animal studies of AD (23). to-
gether, these pathways of stress regulation alter the 
neuroendocrine and inflammatory stress responses 
(15).
the results of the psychoneuroimmunological re-
search carried out so far can be viewed as a strong 
confirmation that stressful events in life are sub-
stantially associated with the functioning of the im-
mune system (20,23,25-30,35). Some clinical studies 
examining the effects of stress on AD manifestations 
supported a strong bond between them. the studies 
discussed below provide strong evidence supporting 
these connections. the study carried out by Kodama 
et al. (on 1,457 respondents) established a connection 
Figure 1. Skin hypothalamic-pituitary-adrenal (HPA) axis 
– the mechanism of stress influence on the HPA axis and 
the immune system (according to lin tK, et al., 2017) (35).
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between natural disaster (earthquake) and AD; aggra-
vations in three groups were established, depending 
on the level of exposure (in a severely damaged area 
– 38.4%; in a lightly damaged area – 29.1%; in an un-
damaged area – 7.0% of patients) (39). Mizawa et al. 
also studied the connection between stress and the 
seriousness of clinical AD manifestations (40). their 
measurements of salivary cortisol as a stress param-
eter and life quality test (Skindex 16) demonstrated 
the impact of stress on AD manifestations. 
Laboratory methods of stress determina-
tion
However, the real impact of stress on AD manifes-
tations is still relatively unknown, primarily due to a 
lack of methods that would objectify and measure 
stress and the lack of reliable parameters that would 
help assess true levels of stress in these patients. 
there are several possible diagnostic methods, pre-
dominantly serum cortisol and, as of late, saliva. 
Stress level determination by serum cortisol
Although both acute and chronic stress can be 
quantified through measurement of changes in phys-
iological indicators (e.g. heart rate, blood pressure, 
levels of metabolic hormones), it is unclear whether 
we can interpret the changes in serum cortisol as re-
flecting acute, chronic, or daily stress variations (32). 
in general, acute cortisol levels fluctuate markedly 
depending on many physiological factors (e.g. circa-
dian rhythm) and may provide a rather poor reflec-
tion of normal, chronic cortisol secretion.
Cortisol secretion in response to stress contributes 
to the suppression of the HPA axis which generally af-
fects health and cognition (32). Since many cortisol 
actions rely on binding to cytosolic receptors, only a 
small fraction of unbound, free cortisol is biologically 
active. in general, serum cortisol levels increase dur-
ing the early morning (highest at about 8 AM) and 
decrease slightly in the evening and during the early 
phase of sleep, so the timing of blood sampling is 
very important (32). 
Serum cortisol remains high during the circadian 
cycle and under different dynamic tests such as ACtH 
stimulation. A high correlation between salivary cor-
tisol levels and unbound cortisol in plasma and se-
rum has been confirmed. 
Stress level determination by salivary 
cortisol
Since free cortisol represents only a fraction of the 
biologically active hormone, salivary cortisol mea-
sures have been considered a better method for the 
evaluation of adrenocortical function (32). thus, saliva 
is an appropriate material for an assessment of stress 
levels in patients. Salivary cortisol values are used for 
the assessment of acute and chronic stress and have 
been in use for some 30 years now (40-46). it is known 
that cortisol levels in saliva serve as an index of acute 
psychological stress, while being a useful index for 
the assessment of chronic stress (43,44). Further-
more, taking saliva samples is a non-invasive method 
that enables gathering of a large number of samples 
in a simple way with no discomfort for the patient. 
the research so far has shown a very good correlation 
between the salivary and plasmatic cortisol. in adults, 
the correlation is approximately 0.75 (46). 
However, numerous factors can affect measure-
ment results of salivary cortisol values (45-47). the 
sex of a patient can impact readings through monthly 
sex hormone cycles, menstrual cycles, hormonal con-
traception usage, pregnancy, breastfeeding, puberty, 
menopause, and possible variabilities in the salivary 
cortisol results. However, they cannot be excluded 
from the sample because it would result in the loss 
of generalizability. Furthermore, the time of sampling 
is important: the smallest number of fluctuations is 
expected late in the afternoon and the maximum 
concentration in the morning (7-10 AM). the time a 
person wakes up, on the other hand, has no relevant 
effect on the morning response of cortisol (47). Other 
factors that can affect the result include intensive 
physical training, high-energy foods, smoking, coffee, 
alcohol, certain medicines (CSs, psychoactive medi-
cines, antidepressants), and psychological factors 
(the ability to deal with stressful situations, social sup-
port, etc.). these are all the potential sources of the 
variance. However, ruling out the potential variances 
would lead to model overlapping and, consequently, 
to false results. this is why as many samples as pos-
sible should be taken (27).
Factors important for stress measurement 
in patients
Both serum and salivary cortisol levels reveal 
acute changes at a single point in time, but the overall 
chronic systemic cortisol exposure is difficult to evalu-
ate due to circadian variations and its protein-binding 
capacity (32). A newer and highly promising tech-
nique is the analysis of cortisol in hair, which assesses 
chronic stress retrospectively. However, salivary corti-
sol may have some advantages over the assessment 
of serum cortisol, while cortisol assessment in sweat 
or tears is only of theoretical importance and urinary 
cortisol is of decreasing interest in diagnostics (32).
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According to recent research, a weak response 
of the salivary cortisol was recorded in patients with 
AD (children and adults) under strong psychosocial 
stress (in other words, lower values of the salivary cor-
tisol were recorded), indicating hypofunction of HPA 
axis (48). At the same time, a weak reaction of the 
HPA axis was observed during intense stress, which 
is a possible explanation for the deterioration of AD 
symptoms as a result of stress.
the fact is, the response of the HPA axis is rather 
complex; it is modulated by numerous factors, which 
can affect diagnostics and diagnostic results. there-
fore, a patient’s subjective stress experience and their 
reaction to stress are very important for the stress 
evaluation and its effect on the disease. Psychological 
tests are helpful as they constitute an additional, very 
valuable evaluation parameter, particularly compared 
with objective lab indicators such as cortisol. the im-
portance that a patient attributes to their disease 
has a stronger influence on their perception of the 
disease than the (real) severity of the disease as such 
(49). it is also important to keep in mind that stress is 
a provocative factor, but is also a consequence of AD. 
in addition to visible changes on the skin and the 
impact of psychological effects, patients with AD face 
another problem – itching. the patients primarily 
identify its intensity with the severity of their disease 
(instead of the intensity of the skin changes). itch-
ing disturbs the sleeping cycle, thus completing the 
circle of stress as both a cause and a consequence of 
AD. Psychological tests are an instrument we can use 
to distinguish acute stress from chronic stress and 
causal stress from resultant stress. 
in addition to the influence of stress on AD, an 
adverse effect of AD on the psychological function-
ing and quality of life of the patients has also been 
observed and described thoroughly in the literature 
(49). it is also important to emphasize that a patient’s 
perception of their disease is strongly influenced by 
their own experience, which the patient attributes 
to their condition more than to the severity of the 
disease as such. the obtained psychoneuroimmune 
data strongly confirm a striking connection between 
life under stress (e.g. due to bereavement, excessive 
workload, or a strong concern about others) and the 
functioning of the immune system. this complex pro-
cess may have an influence on AD manifestations and 
the clinical picture. 
COnCLuSIOn
there are many valuable arguments that show a 
strong connection between psychological stress ex-
posure and occurrence of skin lesions in patients with 
AD. Many pathways that are active when the body is 
under psychological stress may contribute to chang-
es in the patients’ clinical pictures, including HPA axis 
stimulation and dysfunction, along with the neuro-
endocrine system pathways and neurotransmitters 
released in the skin. in diagnostics, aside from mea-
suring serum cortisol, the measurement of salivary 
cortisol has been increasingly used as a non-invasive 
technique that ensures very good correlation to plas-
matic cortisol. 
taking the above into consideration, there is still a 
lack of clinical studies with precise multiple diagnos-
tic procedures that prove a reliable stress influence. As 
precise pathogenic factors and lab indicators during 
psychological stress need to be elucidated, we hope 
that future studies will supplement current knowl-
edge of the influence of psychological stress in AD.
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